DIDS Prevents Ischemic Membrane Degradation in Cultured Hippocampal Neurons by Inhibiting Matrix Metalloproteinase Release

During stroke, cells in the infarct core exhibit rapid failure of their permeability barriers, which releases ions and inflammatory molecules that are deleterious to nearby tissue (the penumbra). Plasma membrane degradation is key to penumbral spread and is mediated by matrix metalloproteinases (MMPs), which are released via vesicular exocytosis into the extracellular fluid in response to stress. DIDS (4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid) preserves membrane integrity in neurons challenged with an in vitro ischemic penumbral mimic (ischemic solution: IS) and we asked whether this action was mediated via inhibition of MMP activity. In cultured murine hippocampal neurons challenged with IS, intracellular proMMP-2 and -9 expression increased 4–10 fold and extracellular latent and active MMP isoform expression increased 2–22 fold. MMP-mediated extracellular gelatinolytic activity increased ∼20–50 fold, causing detachment of 32.1±4.5% of cells from the matrix and extensive plasma membrane degradation (>60% of cells took up vital dyes and >60% of plasma membranes were fragmented or blebbed). DIDS abolished cellular detachment and membrane degradation in neurons and the pathology-induced extracellular expression of latent and active MMPs. DIDS similarly inhibited extracellular MMP expression and cellular detachment induced by the pro-apoptotic agent staurosporine or the general proteinase agonist 4-aminophenylmercuric acetate (APMA). Conversely, DIDS-treatment did not impair stress-induced intracellular proMMP production, nor the intracellular cleavage of proMMP-2 to the active form, suggesting DIDS interferes with the vesicular extrusion of MMPs rather than directly inhibiting proteinase expression or activation. In support of this hypothesis, an antagonist of the V-type vesicular ATPase also inhibited extracellular MMP expression to a similar degree as DIDS. In addition, in a proteinase-independent model of vesicular exocytosis, DIDS prevented stimulus-evoked release of von Willebrand Factor from human umbilical vein endothelial cells. We conclude that DIDS inhibits MMP exocytosis and through this mechanism preserves neuronal membrane integrity during pathological stress.

[1]  G. Haddad,et al.  An in vitro ischemic penumbral mimic perfusate increases NADPH oxidase-mediated superoxide production in cultured hippocampal neurons , 2012, Brain Research.

[2]  G. D. del Zoppo The neurovascular unit, matrix proteases, and innate inflammation , 2010, Annals of the New York Academy of Sciences.

[3]  E. Candelario-Jalil,et al.  Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia , 2009, Neuroscience.

[4]  G. Haddad,et al.  DIDS protects against neuronal injury by blocking Toll‐like receptor 2 activated‐mechanisms , 2009, Journal of neurochemistry.

[5]  Mark Ellisman,et al.  Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells , 2007, Molecular vision.

[6]  藤本 基秋 Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia , 2009 .

[7]  B. McColl,et al.  Systemic Inflammation Alters the Kinetics of Cerebrovascular Tight Junction Disruption after Experimental Stroke in Mice , 2008, The Journal of Neuroscience.

[8]  H. Zhen,et al.  Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. , 2008, Journal of vascular surgery.

[9]  Xiaoming Wang,et al.  DIDS Attenuates Staurosporine-induced Cardiomyocyte Apoptosis by PI3K/Akt Signaling Pathway: Activation of eNOS/NO and Inhibition of Bax Translocation , 2008, Cellular Physiology and Biochemistry.

[10]  E. Lo,et al.  A new penumbra: transitioning from injury into repair after stroke , 2008, Nature Medicine.

[11]  G. Bernardi,et al.  Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion , 2008, Neuroscience.

[12]  G. Haddad,et al.  Role of transporters and ion channels in neuronal injury under hypoxia. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  Jialiang Hu,et al.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases , 2007, Nature Reviews Drug Discovery.

[14]  L. Zitvogel,et al.  Cell death modalities: classification and pathophysiological implications , 2007, Cell Death and Differentiation.

[15]  Jeffrey F. Thompson,et al.  Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  Yousheng Shu,et al.  Factors influencing cell fate in the infarct rim , 2007, Journal of neurochemistry.

[17]  G. Bernardi,et al.  Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. , 2007, International review of neurobiology.

[18]  V. Shoshan-Barmatz,et al.  Characterization of DIDS‐sensitive ATP accumulation in brain synaptic vesicles , 2006, FEBS letters.

[19]  G. Fu,et al.  Anion exchanger 2 mediates the action of arsenic trioxide , 2006, British journal of haematology.

[20]  Guang Cheng,et al.  Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. , 2006, Life sciences.

[21]  R. Loeser,et al.  Chondrocyte cell death mediated by reactive oxygen species-dependent activation of PKC-betaI. , 2006, American journal of physiology. Cell physiology.

[22]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[23]  Takahiro Shimizu,et al.  Volume-sensitive Chloride Channels Involved in Apoptotic Volume Decrease and Cell Death , 2006, The Journal of Membrane Biology.

[24]  N. Takahashi,et al.  Chloride Channel Inhibition Prevents ROSdependentApoptosis Induced by Ischemia-Reperfusion in Mouse Cardiomyocytes , 2005, Cellular Physiology and Biochemistry.

[25]  Jiankun Cui,et al.  A Highly Specific Inhibitor of Matrix Metalloproteinase-9 Rescues Laminin from Proteolysis and Neurons from Apoptosis in Transient Focal Cerebral Ischemia , 2005, The Journal of Neuroscience.

[26]  D. Attwell,et al.  Tonic release of glutamate by a DIDS‐sensitive mechanism in rat hippocampal slices , 2005, The Journal of physiology.

[27]  Hongwei Jin,et al.  Cortical spreading depression activates and upregulates MMP-9. , 2004, The Journal of clinical investigation.

[28]  J. Koziol,et al.  Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix , 2004, Stroke.

[29]  E. Lo,et al.  Role of Matrix Metalloproteinases in Delayed Neuronal Damage after Transient Global Cerebral Ischemia , 2004, The Journal of Neuroscience.

[30]  D. Small,et al.  Disulfonic stilbenes prevent β-amyloid (25–35) neuronal toxicity in rat cortical cultures , 2003, Neuroscience Letters.

[31]  G. Rosenberg Matrix metalloproteinases in neuroinflammation , 2002, Glia.

[32]  Jiankun Cui,et al.  S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death , 2002, Science.

[33]  M. Bullock,et al.  Brain Oxygenation and Energy Metabolism: Part I—Biological Function and Pathophysiology , 2002, Neurosurgery.

[34]  N. Chandel,et al.  Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[35]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[36]  L. Kappos,et al.  Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis , 2001, Brain Research Reviews.

[37]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[38]  C. Guégan,et al.  Specific Caspase Pathways Are Activated in the Two Stages of Cerebral Infarction , 2001, The Journal of Neuroscience.

[39]  S. Bergmann,et al.  Protection of ischemic hearts perfused with an anion exchange inhibitor, DIDS, is associated with beneficial changes in substrate metabolism. , 2001, Cardiovascular research.

[40]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[41]  R. Anderson,et al.  Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. , 1999, Stroke.

[42]  G. Rosenberg,et al.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[43]  D. Koshland,et al.  Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line , 1995, Neuron.

[44]  D. Wagner,et al.  Inducible secretion of large, biologically potent von Willebrand factor multimers , 1986, Cell.

[45]  A. Hansen,et al.  Effect of anoxia on ion distribution in the brain. , 1985, Physiological reviews.

[46]  T. Olsen,et al.  Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. , 1983, Stroke.

[47]  L. Symon,et al.  Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. , 1974, Experimental neurology.

[48]  C. Heidelberger,et al.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. , 1973, Cancer research.